Biotest Farmaceutica Ltda

Company snapshot

Biotest is a global company that supplies plasma protein products and biotherapeutic drugs. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine.

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 4 US patent(s) indexed to this assignee profile.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Biotest Farmaceutica Ltda. Not investment advice.

Recent activity

Latest pipeline, patent, and corporate events for Biotest Farmaceutica Ltda.

1. Jun 8, 2026 Clinical update

   1001 — Phase 3

2. May 9, 2006 Patent grant

   PREPARATION D'IMMUNOGLOBULINE POLYCLONALE CONTENANT DE L'IGM, AUX FINS D'ADMINISTRATION INTRAVEINEUSE, AINSI QUE SA METHODE DE FABRICATION

3. Nov 13, 2000 Patent grant

   Anvendelse af immunoglobulinpræparater til fremstilling af et medikament til oral indgivelse til behandling og forebyggelse

4. Apr 15, 2000 Patent grant

   MENSCHLICHE MONOKLONALE ANTIKÖRPER GEGEN RHESUS D UND ZELLINIEN DIE DIESE PRODUZIEREN

5. Jan 5, 2000 Patent grant

   HUMANISIERTER B-B10, EIN ANTI-IL-2-REZEPTOR-ANTIKÖRPER

View all clinical trial activity →

• What is Biotest Farmaceutica Ltda?

  Biotest Pharma is a pharma organization headquartered in Dreieich, DE. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 3 (1).

• Is Biotest Farmaceutica Ltda publicly traded?

  Biotest Farmaceutica Ltda appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Biotest Farmaceutica Ltda develop or market?

  We link 5 drug profile(s) where Biotest Farmaceutica Ltda is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/biotest-pharma-gmbh#company-drugs.

• What are the latest developments for Biotest Farmaceutica Ltda?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Biotest Farmaceutica Ltda focus on?

  No specific therapeutic focus areas are currently identified for Biotest Farmaceutica Ltda in our database.